LinkedIn image ad examples

Bristol NHS Foundation Trust needs you to help shape the values of one of the largest NHS organisations in the country. Our values are more than just words; they will provide the foundation for how we care for you, make informed decisions, and work together in our teams to improve outcomes for patients and communities. They must also be fit for the future, helping to deliver safer, more connected, fairer and preventative care, while making the best use of public resources. Answer our short survey and share your views.

Bristol NHS Foundation Trust needs you to help shape the values of one of the largest NHS organisations in the country. Our values are more than just words; they will provide the foundation for how we care for you, make informed decisions, and work together in our teams to improve outcomes for patients and communities. They must also be fit for the future, helping to deliver safer, more connected, fairer and preventative care, while making the best use of public resources. Answer our short survey and share your views.

Give your students real tools instead of theory alone. Platform Hub embeds into your existing course: structured learning, hands-on platform access, and a portfolio project every student can show employers.

84 studies tonen minder SSI's, heropnames en heringrepen. Een recente multispecialistische meta-analyse van 84 studies toont aan dat ciNPT geassocieerd is met: ✓ 48% minder SSI's ✓ 46% minder wondcomplicaties ✓ 36% minder heringrepen ✓ 23% minder heropnames Ontdek de wetenschappelijke evidentie achter deze resultaten en de rol die Prevena™ kan spelen binnen de moderne chirurgische praktijk.

Stimmung ist nicht Realität!! Das hat der gestrige AI Summit von WELT einmal mehr gezeigt! Wir haben in Deutschland sensationelle Firmen, Gründerinnen und Gründer sowie Talente — und alle Voraussetzungen, um international ganz vorne mitzuspielen. Ob @Celonis, @NEURA Robotics, @Dash0, @Parloa, @One Data, @IQM Quantum Computers und viele mehr: Hier entsteht Technologie, die global relevant ist. Wir sollten weniger darüber reden, was angeblich nicht geht — und mehr zeigen, was längst passiert.

Our latest blog post explores the metabolism of muvadenant, inspired by a recent paper from Jonny Nachtigall and colleagues. Check out "When spirocycles become metabolic soft spots" at https://lnkd.in/e-yQuUMU! Spirocycles can bring valuable three-dimensionality, tune physicochemical properties and even improve metabolic stability. But what happens when the spirocycle itself becomes a weak point? Muvadenant offers an interesting case study, with metabolism studies revealing oxidative ring opening across two different ring systems. In this article, we explore how spirocycles might be metabolised and ask what this means for medicinal chemists designing metabolically robust drug candidates using these moieties. Source paper: Nachtigall et al. Preclinical pharmacokinetics and biodistribution of the dual adenosine A2A/A2B inhibitor muvadenant (M1069) in rats. Xenobiotica. 2026:1–10. doi: 10.1080/00498254.2026.2720770 #drugmetabolism #drugdesign #medicinalchemistry

オンラインストレージの画像・動画の検索にお困りですか？データベースでファイルを一元管理！豊富な属性情報で管理しづらい画像・動画もすぐに特定！「写真の富士フイルム」ならではのAI類似画像検索など優れた検索・表示機能を搭載し利用申請,承認や時限表示設定,アクセス制限等ファイルの誤用／不正利用の防止機能も充実

Hybrid-DRG in der Urologie: Aus Ambulantisierung wird ein strategischer Hebel. 2.615,37 € Fallpauschale über die Hybrid-DRG L20M – bei entsprechender Fallkonstellation. Doch das wirtschaftliche Potenzial entsteht vor allem durch den passenden Behandlungsprozess. Zwei innovative Lasertherapien von biolitec® zeigen, wie medizinischer Fortschritt, Prozessoptimierung und Wirtschaftlichkeit zusammenspielen können: - Blasensteinbehandlung mit dem Thulium-Faserlaser (TFL) Die minimalinvasive, transurethrale Lithotripsie mit TFL-Lasern ermöglicht ein effizientes Dusting und kann ambulante oder kurzstationäre Behandlungspfade durch kürzere Prozedurzeiten unterstützen und unnötige Sachkosten vermeiden. - TULA® bei nicht-muskelinvasiven Blasentumoren Die transurethrale Laserablation mit dem Diodenlaser kann bei geeigneten Patienten ambulant sowie unter lokaler oder sogar ohne Anästhesie erfolgen. Das schont OP-, Anästhesie- und Bettenkapazitäten – und reduziert gleichzeitig die Belastung für die Patienten. Für Krankenhäuser und urologische Praxen eröffnet das konkrete Chancen: - standardisierte und schlankere Abläufe - geringere Ressourcenbindung je Fall - zusätzliche Kapazitäten in bestehenden Strukturen - patientenorientierte, minimalinvasive Versorgung - Potenzial für eine bessere Wirtschaftlichkeit geeigneter Hybrid-DRG-Fälle Wie können TFL und TULA® die urologischen Prozesse in Ihrem Zentrum verbessern? Erfahren Sie mehr über die innovativen Lasertherapien von biolitec® und ihr medizinisches sowie wirtschaftliches Potenzial. #Urologie #HybridDRG #Ambulantisierung #Lasertherapie #Krankenhausmanagement #MedTech

Every referral is an opportunity to change a life. We’re here to help you make that first connection count.

Een gesloten incisie betekent niet dat het risico verdwenen is. De eerste dagen na de operatie zijn vaak bepalend voor het uiteindelijke resultaat. Ontdek hoe negatieve druktherapie helpt bij het beschermen van de incisie, het afvoeren van vocht en het ondersteunen van een optimale genezingsomgeving. Gebaseerd op uitgebreide klinische ervaring en wetenschappelijke onderbouwing.

Changing mental healthcare starts by changing expectations. GRAND makes care more accessible when Oklahomans are ready, not weeks later.

Is your Net Promoter Score (NPS) above or below world-class? Benchmark your patient experience against private hospitals around the world.

Fat necrosis is the great mimicker. Dr. Robert Ward shares cases of breast cancer recurrence vs. normal changes in post-cryoablation imaging.

Weve been hearing it for a while now: The regulatory submission of the future wont be a document, it will be data. Yet almost nothing about how we work has caught up. Sponsors already hold structured clinical data, structured quality data, structured product data. Health authorities already want to review it as data. And in between, we still lock it inside PDFs so the other side can extract it back out again. Both ends of the conversation are modern. Only the exchange is stuck in 2004. Thats the shift running underneath everything regulatory teams are being asked about right now: eCTD 4.0, IDMP, PQ-CMC, cloud-based review, AI. They get discussed as separate initiatives with separate timelines, but theyre really just one change arriving in pieces. Which is why we built the Future Regulatory Summit around the connections rather than the topics. Two mornings, 18 and 19 November. Steve Gens MSOD opens with the first public look at this years RIM benchmark, and the panels were briefed to cover what didnt work as much as what did. Free, virtual, 10am to 12pm ET. You can register here: https://lnkd.in/eJPAwM3P

🌱 Siamo fieri di presentare la nostra terza Relazione d’Impatto, un documento che racconta il nostro percorso come Società Benefit attraverso risultati, riflessioni e impegni concreti. Per il 2025 abbiamo scelto una parola che racconta chi siamo e la direzione verso cui vogliamo andare: Identità. Un concetto che riflette la volontà di raccontarci con sempre maggiore chiarezza e la nostra evoluzione, con due expert brand complementari, Korian e Kormed, riuniti sotto un’unica realtà: Clariane Italia. Due identità, una missione comune: accompagnare ogni persona dalla prevenzione alla cura. Questa Relazione restituisce il lavoro fatto, gli impatti generati e le sfide che ci attendono, nel segno della trasparenza, dell’ascolto e della responsabilità. Un grazie speciale va a tutte le persone che hanno contribuito a renderla possibile e che, ogni giorno, danno concretezza alla nostra identità. 📖 Scopri la Relazione d’Impatto 2025: https://lnkd.in/e5hFQEEe

More patients, partners, and products shouldn't mean rebuilding interoperability each time you scale. Kodjin FHIR Server gives your digital clinic a production-ready FHIR backbone, so your team spends its time on new services instead of integration plumbing: * Store and exchange clinical data in standard FHIR * Connect EHRs, partners, and apps faster * Support new digital health products on the same foundation Build on FHIR. Scale with confidence.

Alt, hvad du har brug for til at understøtte din lancering af Beltone Illuminate, er nu samlet ét sted. Download startpakken for at få adgang til produktinformation, markedsføringsmateriale og praktiske ressourcer, der er designet til at hjælpe dig med at introducere Beltone Illuminate med tillid.

👓 No todas las lentes antirreflejantes ofrecen la misma experiencia. El tratamiento QUARZ AIRON, aplicado a las lentes progresivas VIMAX, combina tecnología multicapa avanzada para reducir reflejos y mejorar la transparencia, al mismo tiempo que refuerzan la protección frente a la radiación UV. Tecnología diseñada para ofrecer a los usuarios una experiencia visual sin distracciones ni interferencias.

💡 Unlocking the Potential of AI in Radiology: Introducing the ALICIA Project How can #AI transform diagnostic imaging and elevate clinical practice? 🔍 At Bracco, we are exploring the synergy between Artificial Intelligence, contrast agents, and advanced imaging technologies through ALICIA (Artificial Intelligence for Contrast-enhanced ImAging), a five-year research program funded by the Italian Fund for Applied Sciences (FISA). ALICIA focuses on 3 key pillars to shape the future of #radiology: 🔹 Enhanced Precision 🔹 Advanced Integration 🔹 Streamlined Workflows By bringing together cutting-edge technology and real-world clinical validation, we are driving #healthcare toward safer, faster, and more personalized #patient outcomes. 🚀 👉 Follow us for more stories on AI, advanced imaging technologies, and innovation in healthcare. #SustainabilityAtTheCoreOfOurGrowth #Alicia #ArtificialIntelligence

💡 Unlocking the Potential of AI in Radiology: Introducing the ALICIA Project How can #AI transform diagnostic imaging and elevate clinical practice? 🔍 At Bracco, we are exploring the synergy between Artificial Intelligence, contrast agents, and advanced imaging technologies through ALICIA (Artificial Intelligence for Contrast-enhanced ImAging), a five-year research program funded by the Italian Fund for Applied Sciences (FISA). ALICIA focuses on 3 key pillars to shape the future of #radiology: 🔹 Enhanced Precision 🔹 Advanced Integration 🔹 Streamlined Workflows By bringing together cutting-edge technology and real-world clinical validation, we are driving #healthcare toward safer, faster, and more personalized #patient outcomes. 🚀 📖 Read our 2025 Sustainability Report to discover how the ALICIA Project is advancing AI-powered innovation in diagnostic imaging. Page 22. #SustainabilityAtTheCoreOfOurGrowth #Alicia #ArtificialIntelligence

💬 La nostra Relazione d’Impatto 2025 si apre con le parole di Federico Guidoni, Presidente e CEO di #ClarianeItalia, che raccontano una visione della cura capace di guardare al futuro senza perdere di vista ciò che conta davvero. Il cambiamento ci chiede di evolvere, senza perdere ciò che da sempre guida il nostro modo di prenderci cura delle persone: la capacità di ascoltarle e di costruire con loro relazioni basate sulla fiducia. Nel 2025 questa visione ha continuato a tradursi in scelte concrete, con l’obiettivo di costruire un modello di cura capace di innovare e, allo stesso tempo, di rimanere profondamente umano. È questo equilibrio tra innovazione e relazione a definire il nostro percorso e a guidare il nostro impegno per il futuro. 📖 Scopri la Relazione d’Impatto 2025 e la visione che guida il nostro percorso: https://lnkd.in/e5hFQEEe

Få adgang til de værktøjer og ressourcer, du har brug for, for at gøre hver eneste tilpasning af Beltone Illuminate til en succes. Download startpakken for at få produktinformation, lanceringsmateriale og markedsføringsmateriale, der kan støtte din virksomhed og dine kunder.

Kodjin Analytics is a healthcare data management and analytics platform. It brings clinical data from FHIR, openEHR and other sources into one governed analytical layer and makes it usable: dashboards and reporting, cohort and population analysis, pathway insights, natural-language querying, AI-driven use cases and research. The result is clinical data that serves as a shared asset for insight and day-to-day operational decisions.

Deadline this weekend: Apply by 11 October to join our four-month therapeutic accelerator and get hands-on support to advance your oncology therapeutic towards patient impact.